Showing 2,683 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Promising data bodes well for all-Achillion hep C treatment

Editor's pick
Reuters
10 February 2015
New & experimental hepatitis C treatment

Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

Editor's pick
Achillion press release
9 February 2015
Hepatitis C treatment

Worldwide treatment of hepatitis C could be within sight at the right cost

Editor's pick
Imperial College press release
9 February 2015
Finance & funding

Obama Budget Boosts U.S. HIV and Hepatitis Funding, Cuts Global AIDS and TB

Editor's pick
HIVandHepatitis.com
9 February 2015
Access to healthcare

Portugal agrees to treat 13,000 hepatitis C patients

Editor's pick
Xinhua
9 February 2015
Hepatitis C treatment

What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean

Editor's pick
Wall Street Journal (blog)
5 February 2015
Hepatitis C treatment

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

Editor's pick
New York Times
5 February 2015
Hepatitis B

Hepatitis Quest Moves From C to B Under Former Gilead Executives

Editor's pick
Bloomberg
5 February 2015
Hepatitis C transmission & prevention

Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention

Editor's pick
Medical Xpress
5 February 2015
New & experimental hepatitis C treatment

Merck says hepatitis C drugs to lose breakthrough status

Editor's pick
Reuters
5 February 2015
Finance & funding

How Hepatitis C Is Shining A Light On Critical Gaps In Payment Reform

Editor's pick
Health Affairs (blog)
4 February 2015
Hepatitis C transmission & prevention

ChemSex and HCV transmission among UK MSM

Editor's pick
BMJ Group blogs
3 February 2015
Access to healthcare

Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

Editor's pick
TAG
3 February 2015
Pharmaceutical industry

AbbVie Inc stock drops after expectations for Viekira Pak fall short

Editor's pick
Bidness Etc
2 February 2015
New & experimental hepatitis C treatment

AbbVie next-generation hepatitis C drugs look promising in early studies

News
30 January 2015
Access to healthcare

Hepatitis C drug access: Europe is the new Africa

Editor's pick
HIV i-Base
30 January 2015
Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
Hepatitis C treatment

German insurers win discounts on Gilead's Sovaldi

Editor's pick
Yahoo News
26 January 2015
Hepatitis C treatment

Merck discontinues Victrelis (boceprevir) voluntarily in the United States

Editor's pick
EATG
21 January 2015
Hepatitis C transmission & prevention

Vertical transmission of HCV: The next big treatment frontier

Editor's pick
EATG
20 January 2015
Hepatitis C symptoms & diagnosis

UNITAID publishes comprehensive review of detection and monitoring technologies for hepatitis C

Editor's pick
UNITAID press release
20 January 2015
Hepatitis C treatment

Gilead and AbbVie take hepatitis C battle to Europe

Editor's pick
Financial Times (free registration required)
20 January 2015